Various inflammatory pathways showed marked inhibition by budesonide in all cell variants and airway tissue, including “NF-κB signaling”, “TNFR1 and 2 signaling”, “B cell activating factor signaling”, “osteoarthritis pathway” and “toll-like receptor signaling”. The gene discussed is TNFRSF1A; the disease is osteoarthritis.